1 Here, we choose
facioscapulohumeral dystrophy (FSHD) as a model to deter
2 Facioscapulohumeral dystrophy (FSHD) has a unique geneti
3 n of DUX4 in skeletal muscle as the cause of
facioscapulohumeral dystrophy (FSHD) has led to rational
4 nces in understanding the pathophysiology of
facioscapulohumeral dystrophy (FSHD) have led to several
5 nces in understanding the pathophysiology of
facioscapulohumeral dystrophy (FSHD) have led to the dis
6 Facioscapulohumeral dystrophy (FSHD) is associated with
7 Facioscapulohumeral dystrophy (FSHD) is caused by decrea
8 Facioscapulohumeral dystrophy (FSHD) is caused by the mi
9 Facioscapulohumeral dystrophy (FSHD) is one of the most
10 Facioscapulohumeral dystrophy (FSHD) is one of the most
11 atin repressor, which is mutated in > 95% of
Facioscapulohumeral dystrophy (FSHD) type 2 cases.
12 For adults with
Facioscapulohumeral dystrophy (FSHD), vibratory proprioc
13 expression of DUX4 in skeletal muscle causes
facioscapulohumeral dystrophy (FSHD), whereas expression
14 ressed in nearly all somatic tissue, whereas
facioscapulohumeral dystrophy (FSHD)-causing mutations r
15 d in several cancers and diseases, including
facioscapulohumeral dystrophy (FSHD).
16 Its misexpression in skeletal muscle causes
facioscapulohumeral dystrophy (FSHD).
17 ion of DUX4 in skeletal muscle and can cause
facioscapulohumeral dystrophy (FSHD).
18 pecifically, the 4q35 subtelomere mutated in
facioscapulohumeral dystrophy (FSHD).
19 Facioscapulohumeral dystrophy (FSHD; MIM158900, MIM15890
20 Facioscapulohumeral dystrophy is an autosomal dominant m
21 Facioscapulohumeral dystrophy type 1 (FSHD-1) is the mos
22 ular dystrophies (Becker muscular dystrophy,
facioscapulohumeral dystrophy, and limb-girdle muscular
23 ms, electrocardiograms, and in subjects with
facioscapulohumeral dystrophy, funduscopic and audiometr
24 o critically involved in the pathogenesis of
facioscapulohumeral dystrophy.
25 myodystrophy (myd), is a candidate model for
facioscapulohumeral dystrophy.
26 rious limb girdle MDs, myotonic dystrophy 1,
facioscapulohumeral MD, dysferlinopathies and congenital
27 muscles with iliopsoas sparing is common in
facioscapulohumeral muscular dystrophy (67% of the patie
28 SP syndromes can resemble
facioscapulohumeral muscular dystrophy (FSH) due to scap
29 strate that cells derived from patients with
facioscapulohumeral muscular dystrophy (FSHD) activate h
30 Facioscapulohumeral muscular dystrophy (FSHD) affects ro
31 the D4Z4 copy numbers, a known biomarker for
facioscapulohumeral muscular dystrophy (FSHD) and estima
32 mbryos, whereas misexpression of DUX4 causes
facioscapulohumeral muscular dystrophy (FSHD) and is ass
33 ng valid approaches for genetic diagnosis in
facioscapulohumeral muscular dystrophy (FSHD) and MUC1-a
34 With several therapeutic strategies for
facioscapulohumeral muscular dystrophy (FSHD) entering c
35 Advances in the molecular understanding of
facioscapulohumeral muscular dystrophy (FSHD) have revea
36 Facioscapulohumeral muscular dystrophy (FSHD) involves s
37 Facioscapulohumeral muscular dystrophy (FSHD) is a commo
38 Facioscapulohumeral muscular dystrophy (FSHD) is a commo
39 Facioscapulohumeral muscular dystrophy (FSHD) is a debil
40 Facioscapulohumeral muscular dystrophy (FSHD) is a degen
41 Facioscapulohumeral muscular dystrophy (FSHD) is a genet
42 Facioscapulohumeral muscular dystrophy (FSHD) is a hered
43 Facioscapulohumeral muscular dystrophy (FSHD) is a muscu
44 Facioscapulohumeral muscular dystrophy (FSHD) is a myopa
45 Facioscapulohumeral muscular dystrophy (FSHD) is a neuro
46 Facioscapulohumeral muscular dystrophy (FSHD) is a poten
47 Facioscapulohumeral muscular dystrophy (FSHD) is a preva
48 Facioscapulohumeral muscular dystrophy (FSHD) is a preva
49 Facioscapulohumeral muscular dystrophy (FSHD) is a preva
50 Facioscapulohumeral muscular dystrophy (FSHD) is a preva
51 Facioscapulohumeral muscular dystrophy (FSHD) is a preva
52 Facioscapulohumeral muscular dystrophy (FSHD) is a progr
53 Facioscapulohumeral muscular dystrophy (FSHD) is a progr
54 Facioscapulohumeral muscular dystrophy (FSHD) is a uniqu
55 Facioscapulohumeral muscular dystrophy (FSHD) is an auto
56 Facioscapulohumeral muscular dystrophy (FSHD) is an auto
57 Facioscapulohumeral muscular dystrophy (FSHD) is an auto
58 Facioscapulohumeral muscular dystrophy (FSHD) is an auto
59 Facioscapulohumeral muscular dystrophy (FSHD) is an auto
60 Facioscapulohumeral muscular dystrophy (FSHD) is an auto
61 Facioscapulohumeral muscular dystrophy (FSHD) is an auto
62 Facioscapulohumeral muscular dystrophy (FSHD) is an incu
63 Facioscapulohumeral muscular dystrophy (FSHD) is an incu
64 Facioscapulohumeral muscular dystrophy (FSHD) is an inhe
65 Facioscapulohumeral muscular dystrophy (FSHD) is associa
66 Facioscapulohumeral muscular dystrophy (FSHD) is caused
67 Facioscapulohumeral muscular dystrophy (FSHD) is caused
68 Facioscapulohumeral muscular dystrophy (FSHD) is caused
69 Facioscapulohumeral muscular dystrophy (FSHD) is caused
70 Facioscapulohumeral muscular dystrophy (FSHD) is caused
71 Facioscapulohumeral muscular dystrophy (FSHD) is caused
72 Facioscapulohumeral muscular dystrophy (FSHD) is caused
73 In most cases
facioscapulohumeral muscular dystrophy (FSHD) is caused
74 Facioscapulohumeral muscular dystrophy (FSHD) is caused
75 Facioscapulohumeral muscular dystrophy (FSHD) is caused
76 Facioscapulohumeral muscular dystrophy (FSHD) is charact
77 Facioscapulohumeral muscular dystrophy (FSHD) is charact
78 Facioscapulohumeral muscular dystrophy (FSHD) is linked
79 Facioscapulohumeral muscular dystrophy (FSHD) is linked
80 Facioscapulohumeral muscular dystrophy (FSHD) is linked
81 Facioscapulohumeral muscular dystrophy (FSHD) is one of
82 Facioscapulohumeral muscular dystrophy (FSHD) is one of
83 Facioscapulohumeral muscular dystrophy (FSHD) is one of
84 Facioscapulohumeral muscular dystrophy (FSHD) may be a n
85 ce places the subtelomeric defect underlying
facioscapulohumeral muscular dystrophy (FSHD) much close
86 sion in skeletal muscles plays a key role in
facioscapulohumeral muscular dystrophy (FSHD) pathogenes
87 Facioscapulohumeral muscular dystrophy (FSHD) results fr
88 The neuromuscular disorder
facioscapulohumeral muscular dystrophy (FSHD) results fr
89 ons in SMCHD1 that have been associated with
facioscapulohumeral muscular dystrophy (FSHD) type 2.
90 subtelomeric region of chromosome 4q causes
facioscapulohumeral muscular dystrophy (FSHD) when occur
91 ms, and its aberrant expression is linked to
facioscapulohumeral muscular dystrophy (FSHD) where it h
92 Facioscapulohumeral muscular dystrophy (FSHD), a common
93 ubtelomeric region, 4q35.2, is implicated in
facioscapulohumeral muscular dystrophy (FSHD), a dominan
94 deformation (strain) in patients affected by
facioscapulohumeral muscular dystrophy (FSHD), a prevale
95 c transcription factor and causative gene of
facioscapulohumeral muscular dystrophy (FSHD), induces t
96 The method is applied here to study
facioscapulohumeral muscular dystrophy (FSHD), simultane
97 Facioscapulohumeral muscular dystrophy (FSHD), the most
98 ce best supports an epigenetic mechanism for
facioscapulohumeral muscular dystrophy (FSHD), whereby d
99 expression of DUX4 in skeletal muscle causes
facioscapulohumeral muscular dystrophy (FSHD).
100 hose misexpression in skeletal muscle causes
facioscapulohumeral muscular dystrophy (FSHD).
101 keletal muscle, however, is toxic and causes
facioscapulohumeral muscular dystrophy (FSHD).
102 DUX4 is associated with the pathogenesis of
Facioscapulohumeral muscular dystrophy (FSHD).
103 homeodomain transcription factor DUX4 causes
facioscapulohumeral muscular dystrophy (FSHD).
104 the underlying molecular genetic changes in
facioscapulohumeral muscular dystrophy (FSHD).
105 f human chromosome 4q contains the locus for
facioscapulohumeral muscular dystrophy (FSHD).
106 causes muscle deterioration and weakness in
Facioscapulohumeral muscular dystrophy (FSHD).
107 chromosome 4q contains the locus involved in
facioscapulohumeral muscular dystrophy (FSHD1).
108 olemma of skeletal muscle from patients with
facioscapulohumeral muscular dystrophy (FSHD1A) to learn
109 ted with the age-associated genetic disease,
facioscapulohumeral muscular dystrophy (FSHD1A, MIM 1589
110 shed SMCHD1 function in muscle fibers causes
Facioscapulohumeral Muscular Dystrophy (FSHD2) through d
111 Facioscapulohumeral muscular dystrophy (FSHD: MIM#158900
112 included adults aged 18-65 years with type 1
facioscapulohumeral muscular dystrophy (ie, with loss of
113 ations of chromatin structure: ICF syndrome,
facioscapulohumeral muscular dystrophy and a case of alp
114 ancer, Scissor was effective in interpreting
facioscapulohumeral muscular dystrophy and Alzheimer's d
115 are consistent with a model that configures
facioscapulohumeral muscular dystrophy as a "muscle-by-m
116 it also results in enhanced silencing at the
facioscapulohumeral muscular dystrophy associated macros
117 scle MRI can be also used for distinguishing
facioscapulohumeral muscular dystrophy from other myopat
118 Facioscapulohumeral muscular dystrophy is a hereditary p
119 rs in facioscapulohumeral muscular dystrophy.
Facioscapulohumeral muscular dystrophy is a severe myopa
120 Facioscapulohumeral muscular dystrophy is a slowly progr
121 he validity of the human graft as a model of
facioscapulohumeral muscular dystrophy is demonstrated i
122 ctive X chromosome, imprinted genes, and the
facioscapulohumeral muscular dystrophy locus.
123 most frequent are the dystrophinopathies and
facioscapulohumeral muscular dystrophy making up 22.9% (
124 fficient, and use this finding to develop an
facioscapulohumeral muscular dystrophy mouse model with
125 of disease, iMyoblasts from individuals with
Facioscapulohumeral Muscular Dystrophy revealed a previo
126 SMCHD1 mutations cause
facioscapulohumeral muscular dystrophy type 2 (FSHD2) vi
127 ic inheritance and an epigenetic modifier in
facioscapulohumeral muscular dystrophy type 2.
128 ular dystrophy: Duchenne muscular dystrophy,
facioscapulohumeral muscular dystrophy, and myotonic dys
129 beginning of this disease-associated array (
facioscapulohumeral muscular dystrophy, FSHD) despite se
130 5 near the heterochromatic region mutated in
facioscapulohumeral muscular dystrophy, indicating a pos
131 dystrophy (DMD), Becker muscular dystrophy,
facioscapulohumeral muscular dystrophy, limb-girdle musc
132 Here we show that the endogenous
facioscapulohumeral muscular dystrophy-specific DUX4 pol
133 ge repair, and mutations in SMCHD1 can cause
facioscapulohumeral muscular dystrophy.
134 a phase 3 study of losmapimod in adults with
facioscapulohumeral muscular dystrophy.
135 sion, and p38beta MAPK) for the treatment of
facioscapulohumeral muscular dystrophy.
136 ate the degree of pathology in patients with
facioscapulohumeral muscular dystrophy.
137 on chromosome 4 that is partially deleted in
facioscapulohumeral muscular dystrophy.
138 wn-regulation of ALP does not participate in
facioscapulohumeral muscular dystrophy.
139 e 4q35 and was identified as a candidate for
facioscapulohumeral muscular dystrophy.
140 nvolvement of fibroadipogenic progenitors in
facioscapulohumeral muscular dystrophy.Facioscapulohumer
141 lated to be affected by mutations that cause
facioscapulohumeral muscular dystrophy; thus, the charac
142 Duchenne and Becker; Emery-Dreifuss; distal;
facioscapulohumeral;
oculopharyngeal; and limb-girdle wh